Capecitabine, DNA/RNA Synthesis Inhibitor

Por um escritor misterioso

Descrição

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
Capecitabine, DNA/RNA Synthesis Inhibitor
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
is a tumor-selective fluoropyrimidine carbamate, which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU.
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine
Capecitabine, DNA/RNA Synthesis Inhibitor
View of Genetic factors affecting patient responses to pancreatic cancer treatment
Capecitabine, DNA/RNA Synthesis Inhibitor
Why Great Mitotic Inhibitors Make Poor Cancer Drugs: Trends in Cancer
Capecitabine, DNA/RNA Synthesis Inhibitor
HY-17371-100mg Oxaliplatin [61825-94-3] Hexabiogen
Capecitabine, DNA/RNA Synthesis Inhibitor
Frontiers 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine, Drug Information, Uses, Side Effects, Chemistry
Capecitabine, DNA/RNA Synthesis Inhibitor
5-FU (5-Fluorouracil), 99.97%(HPLC), In Stock
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine-d11, Stable Isotope
Capecitabine, DNA/RNA Synthesis Inhibitor
Effects of microbiota on anticancer drugs: Current knowledge and potential applications - eBioMedicine
de por adulto (o preço varia de acordo com o tamanho do grupo)